Cargando…

A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering

Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haitao, Wang, Yaqing, Wang, Hui, Zhao, Mengqian, Tao, Tingting, Zhang, Xu, Qin, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284190/
https://www.ncbi.nlm.nih.gov/pubmed/32537414
http://dx.doi.org/10.1002/advs.201903739
_version_ 1783544411261501440
author Liu, Haitao
Wang, Yaqing
Wang, Hui
Zhao, Mengqian
Tao, Tingting
Zhang, Xu
Qin, Jianhua
author_facet Liu, Haitao
Wang, Yaqing
Wang, Hui
Zhao, Mengqian
Tao, Tingting
Zhang, Xu
Qin, Jianhua
author_sort Liu, Haitao
collection PubMed
description Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is developed for controllable fabrication of hybrid hydrogel capsules, which allows for massive 3D culture and formation of functional and uniform islet organoids derived from human‐induced pluripotent stem cells (hiPSCs). In this all‐in‐water microfluidic system, an array of droplets is utilized as templates for one‐step fabrication of binary capsules relying on interfacial complexation of oppositely charged Na‐alginate (NaA) and chitosan (CS). The produced hybrid capsules exhibit high uniformity, and are biocompatible, stable, and permeable. The established system enables capsule production, 3D culture, and self‐organizing formation of human islet organoids in a continuous process by encapsulating pancreatic endocrine cells from hiPSCs. The generated islet organoids contain islet‐specific α‐ and β‐like cells with high expression of pancreatic hormone specific genes and proteins. Moreover, they exhibit sensitive glucose‐stimulated insulin secretion function, demonstrating the capability of these binary capsules to engineer human organoids from hiPSCs. The proposed system is scalable, easy‐to‐operate, and stable, which can offer a robust platform for advancing human organoids research and translational applications.
format Online
Article
Text
id pubmed-7284190
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72841902020-06-11 A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering Liu, Haitao Wang, Yaqing Wang, Hui Zhao, Mengqian Tao, Tingting Zhang, Xu Qin, Jianhua Adv Sci (Weinh) Communications Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is developed for controllable fabrication of hybrid hydrogel capsules, which allows for massive 3D culture and formation of functional and uniform islet organoids derived from human‐induced pluripotent stem cells (hiPSCs). In this all‐in‐water microfluidic system, an array of droplets is utilized as templates for one‐step fabrication of binary capsules relying on interfacial complexation of oppositely charged Na‐alginate (NaA) and chitosan (CS). The produced hybrid capsules exhibit high uniformity, and are biocompatible, stable, and permeable. The established system enables capsule production, 3D culture, and self‐organizing formation of human islet organoids in a continuous process by encapsulating pancreatic endocrine cells from hiPSCs. The generated islet organoids contain islet‐specific α‐ and β‐like cells with high expression of pancreatic hormone specific genes and proteins. Moreover, they exhibit sensitive glucose‐stimulated insulin secretion function, demonstrating the capability of these binary capsules to engineer human organoids from hiPSCs. The proposed system is scalable, easy‐to‐operate, and stable, which can offer a robust platform for advancing human organoids research and translational applications. John Wiley and Sons Inc. 2020-04-11 /pmc/articles/PMC7284190/ /pubmed/32537414 http://dx.doi.org/10.1002/advs.201903739 Text en © 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communications
Liu, Haitao
Wang, Yaqing
Wang, Hui
Zhao, Mengqian
Tao, Tingting
Zhang, Xu
Qin, Jianhua
A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title_full A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title_fullStr A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title_full_unstemmed A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title_short A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
title_sort droplet microfluidic system to fabricate hybrid capsules enabling stem cell organoid engineering
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284190/
https://www.ncbi.nlm.nih.gov/pubmed/32537414
http://dx.doi.org/10.1002/advs.201903739
work_keys_str_mv AT liuhaitao adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT wangyaqing adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT wanghui adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT zhaomengqian adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT taotingting adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT zhangxu adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT qinjianhua adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT liuhaitao dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT wangyaqing dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT wanghui dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT zhaomengqian dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT taotingting dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT zhangxu dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering
AT qinjianhua dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering